Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
Titel:
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
Auteur:
Weekes, Colin D. Rosen, Lee S. Capasso, Anna Wong, Kit Man Ye, Weilan Anderson, Maria McCall, Bruce Fredrickson, Jill Wakshull, Eric Eppler, Steve Shon-Nguyen, Quyen Desai, Rupal Huseni, Mahrukh Hegde, Priti S. Pourmohamad, Tony Rhee, Ina Bessudo, Alberto